| Evotec AG. (11/21/18). "Press Release: Evotec and Immuneering to Collaborate on Artifical Intelligence (“AI”) Driven Ligand Identification for Rare Hereditary Metabolic Diseases". Hamburg & Cambridge, MA. |
2018-11-21 |
| BRAIN AG. (11/21/18). "Press Release: Manfred Bender Set to Join BRAIN AG’s Management Board as Chief Financial Officer (CFO)". Zwingenberg. |
2018-11-21 |
| InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena. |
2018-11-21 |
| Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million". Pratteln & Allschwil. |
2018-11-21 |
| Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone". Pratteln & Allschwil. |
2018-11-21 |
| 3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. |
2018-11-20 |
| Merck KGaA. (11/19/18). "Press Release: Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer. Joint Venture between Merck and Palantir Technologies Being Created to Advance Cancer Research". Palo Alto, CA. |
2018-11-19 |
| Immunocore Ltd.. (11/19/18). "Press Release: Immunocore to Co-develop IMC-C103C, a T Cell Redirecting Bi-specific Biologic, with Genentech". Oxford & Conshohocken, PA. |
2018-11-19 |
| Lonza Group AG. (11/19/18). "Press Release: Lonza Opens Collaborative Innovation Center in Haifa, Israel". Haifa. |
2018-11-19 |
| Merck KGaA. (11/19/18). "Press Release: Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer [Not intended for US, Canada and UK-based media]". Darmstadt. |
2018-11-19 |
| Marinomed Biotech AG. (11/16/18). "Press Release: Marinomed Determines IPO Timeline and Terms [Adhoc-News]". |
2018-11-16 |
| Mologen AG. (11/16/18). "Press Release: Mologen AG to Retain Rights to Lefitolimod – Termination of Negotiations with Oncologie Inc. and Assessment of All Strategic Options in the Light of a Likely Read-out of the Pivotal Phase III IMPALA Trial in 2019". |
2018-11-16 |
| Apceth Biopharma GmbH. (11/16/18). "Press Release: Apceth Biopharma GmbH Manufactures DCprime’s Cell-based Cancer Vaccine for Phase II Clinical Study". Munich. |
2018-11-16 |
| Noxxon Pharma N.V.. (11/16/18). "Press Release: Noxxon Announces € 6.2 Million Equity Capital Raise including US$ 5 Million from US Family Office – Acuitas Capital, LLC. Noxxon Ends the Use of Variable Rate Equity Financing with Yorkville". Berlin. |
2018-11-16 |
| Centogene AG. (11/16/18). "Press Release: Centogene Announces CentoPharma, World’s First Platform for Targeted Patient Cohort Identification". Rostock. |
2018-11-16 |
| Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. |
2018-11-15 |
| NBE Therapeutics AG. (11/15/18). "Press Release: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE Therapeutics". Basel. |
2018-11-15 |
| Cadent Therapeutics. (11/15/18). "Press Release: Cadent Therapeutics Secures $40 Million Series B Financing to Advance Pipeline of Novel Therapies for Movement and Cognitive Disorders". Cambridge, MA. |
2018-11-15 |
| MorphoSys AG. (11/15/18). "Press Release: MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210". Planegg. |
2018-11-15 |
| Boehringer Ingelheim. (11/15/18). "Press Release: Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies". Cambridge, MA & Ingelheim. |
2018-11-15 |
| Hookipa Pharma Inc.. (11/14/18). "Press Release: Hookipa Appoints Julie O’Neill as a Non-Executive Director". New York, NY & Vienna. |
2018-11-14 |
| Bruker Corporation. (11/14/18). "Press Release: Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH". Billerica. |
2018-11-14 |
| Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. |
2018-11-13 |
| Evotec AG. (11/13/18). "Press Release: Evotec AG Reports First Nine-months 2018 Results and Corporate Updates". Hamburg. |
2018-11-13 |
| Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. |
2018-11-12 |
| Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. |
2018-11-12 |
| Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. |
2018-11-12 |
| Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. |
2018-11-12 |
| Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. |
2018-11-12 |
| Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin. |
2018-11-12 |
| Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U |
2018-11-12 |
| Scienion AG. (11/9/18). "Press Release: R2R Biofluidics EU Project Recently Received the Austrian Fast Forward Award 2018". Berlin. |
2018-11-09 |
| CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. |
2018-11-09 |
| Arsanis, Inc.. (11/9/18). "Press Release: Arsanis Reports Financial Results for Third Quarter 2018". Waltham, MA & Vienna. |
2018-11-09 |
| Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin. |
2018-11-08 |
| Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. |
2018-11-08 |
| Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO". |
2018-11-08 |
| CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-11-07 |
| Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-11-07 |
| Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. |
2018-11-06 |
| ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin. |
2018-11-06 |
| Spark Therapeutics, Inc.. (11/6/18). "Press Release: Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress". Philadeliphia, PA. |
2018-11-06 |
| Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. |
2018-11-06 |
| Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. |
2018-11-05 |
| Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. |
2018-11-05 |
| Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. |
2018-11-05 |
| Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. |
2018-11-05 |
| MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. |
2018-11-05 |
| BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. |
2018-11-05 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. |
2018-11-02 |
| Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. |
2018-11-02 |
| Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol |
2018-11-02 |
| Centogene AG. (11/2/18). "Press Release: Centogene Further Expands Executive Team, Appoints Oved Amitay as Chief Business Officer – Increases Focus on Pharma Partnerships". Rostock. |
2018-11-02 |
| Nabriva Therapeutics plc. (11/1/18). "Press Release: Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections". Dublin. |
2018-11-01 |
| Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. |
2018-11-01 |
| Boehringer Ingelheim. (10/31/18). "Press Release: Boehringer Ingelheim Achieves Next Expansion Milestone in Biologics Production in the US". Fremont, CA. |
2018-10-31 |
| [iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2018-10-31 |
| PerkinElmer, Inc.. (10/31/18). "Press Release: PerkinElmer Announces Financial Results for the Third Quarter of 2018". Waltham, MA. |
2018-10-31 |
| BioM Biotech Cluster Development GmbH. (10/30/18). "Pressemitteilung: BioM erhält Auftrag zur Projektkoordination von »DigiMed Bayern«. Bayerisches Gesundheitsministerium fördert das medizinische Digitalisierungsvorhaben mit 20 Millionen Euro über 5 Jahr |
2018-10-30 |
| Harpoon Therapeutics, Inc.. (10/30/18). "Press Release: Harpoon Therapeutics Announces Appointment of Ms. Georgia L. Erbez to Chief Financial Officer and Promotion of Holger Wesche, Ph.D., to Chief Scientific Officer". South San Francisco, CA. |
2018-10-30 |
| Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. |
2018-10-30 |
| Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. |
2018-10-29 |
| Thermo Fisher Scientific Inc.. (10/29/18). "Press Release: Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins". Sunnyvale, CA. |
2018-10-29 |
| Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. |
2018-10-29 |
| Boehringer Ingelheim. (10/26/18). "Press Release: Boehringer Ingelheim Inaugurates New Centre for Agile Working Methods – More and Better Health Solutions for Humans and Animals". Ingelheim. |
2018-10-26 |
| Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. |
2018-10-26 |
| Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. |
2018-10-24 |
| BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC. |
2018-10-24 |
| Intrexon Corporation. (10/24/18). "Press Release: Intrexon Announces the Formation of Bioinformatics Hub in Munich. Establishing itself as Intrexon Bioinformatics Germany GmbH (IBG)". Germantown, MD. |
2018-10-24 |
| Novartis AG. (10/23/18). "Press Release: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery". Fort Worth, TX. |
2018-10-23 |
| Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. |
2018-10-23 |
| Validogen GmbH. (10/22/18). "Press Release: Change of Company Name – VTU Technology Is Now Validogen". Raaba-Grambach. |
2018-10-22 |
| Boehringer Ingelheim. (10/19/18). "Press Release: Real-world Study Shows Using Giotrif/Gilotrif (afatinib) Followed by Osimertinib Provides a Median of 27.6 Months of Chemotherapy-free Time in Patients with EGFR Mutation-positive NSCLC". Ingelheim. |
2018-10-19 |
| Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. |
2018-10-19 |
| Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)". |
2018-10-19 |
| Novartis AG. (10/18/18). "Press Release: Novartis Announces Planned Acquisition of Endocyte to Expand Expertise in Radiopharmaceuticals and Build on Commitment to Transformational Therapeutic Platforms". Basel. |
2018-10-18 |
| Protagen AG. (10/18/18). "Press Release: The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend Their Collaboration to Investigate the Immuno-competence of Urothelial Cancer Patients Receiving Immunotherapy". |
2018-10-18 |
| Selexis S.A.. (10/18/18). "Press Release: Selexis and Berkeley Lights Collaborate to Accelerate Cell Line Development with the Beacon Optofluidic Platform". Geneva. |
2018-10-18 |
| OLS Omni Life Science GmbH & Co. KG. (10/18/18). "Press Release: CERO Is a Novel 3D Cell Cultivation System". Bremen. |
2018-10-18 |
| Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. |
2018-10-18 |
| Oncgnostics GmbH. (10/17/18). "Press Release: Cervical Cancer Screening. Oncgnostics Closes further Investment Round". Jena. |
2018-10-17 |
| ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. |
2018-10-16 |
| Bruker Corporation. (10/16/18). "Press Release: Bruker Launches the S2 Polar High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry". Galveston, TX. |
2018-10-16 |
| Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA. |
2018-10-16 |
| Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. |
2018-10-16 |
| Quantum Analytics. (10/16/18). "Press Release: New Distribution Agreement with Bruker AXS". Foster City, CA. |
2018-10-16 |
| Revolution Medicines, Inc.. (10/16/18). "Press Release: Revolution Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets". Redwood City, CA & Cambridge, MA. |
2018-10-16 |
| F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. |
2018-10-15 |
| Boehringer Ingelheim. (10/12/18). "Press Release: Boehringer Ingelheim Inaugurates Its New Global Centre for Veterinary Vaccine R&D in Lyon, France". Lyon. |
2018-10-12 |
| Miltenyi Biotec GmbH. (10/12/18). "Press Release: Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec". Bergisch Gladbach & Bielefeld. |
2018-10-12 |
| Evotec AG. (10/11/18). "Press Release: Evotec and Celgene Expand iPSC Collaboration to Include additional Cell Lines. $6M Payment to Access additional Cell Lines". Hamburg. |
2018-10-11 |
| Curetis N.V.. (10/11/18). "Press Release: Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-10-11 |
| Metabolon, Inc.. (10/11/18). "Press Release: Metabolon Enters into Debt Agreement with Innovatus Life Sciences and East West Bank". Research Triangle Park, NC. |
2018-10-11 |
| Bruker Corporation. (10/11/18). "Press Release: First Global Installation of 9.4 Tesla Preclinical MRI System Combined with PET at The German Cancer Research Center (DKFZ)". Billerica, MA. |
2018-10-11 |
| European Commission. (10/11/18). "Press Release: A New Bioeconomy Strategy for a Sustainable Europe. Commission Puts Forward an Action Plan to Develop a Sustainable and Circular Bioeconomy that Serves Europe's Society, Environment and Economy". Brussels. |
2018-10-11 |
| EBD Group. (10/11/18). "Press Release: BIO-Europe 2018 to Bring 4,000 Life Science Leaders to Copenhagen November 5–7". Carlsbad, CA & Copenhagen. |
2018-10-11 |
| Qiagen N.V.. (10/11/18). "Press Release: Qiagen Launches Novel RNA-seq Library Preparation Solutions for Next-generation Sequencing". Hilden & Germantown, MD. |
2018-10-11 |
| CRISPR Therapeutics AG. (10/10/18). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Zug, Boston, MA & Cambridge, MA |
2018-10-10 |
| Gotham Therapeutics Corporation. (10/10/18). "Press Release: Gotham Therapeutics Launches with $54 Million Series A". New York, NY. |
2018-10-10 |
| Forbion Capital Partners. (10/10/18). "Press Release: Forbion Co-leads $54m Series A Financing in Newly Formed Gotham Therapeutics". Naarden & Munich. |
2018-10-10 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
1 2 3 4 ... 97 98 99 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
